Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Vaccinex, Inc. per 2024 Dec 31 adalah 0.60 MM.
- Nilai operating income untuk Vaccinex, Inc. per 2024 Dec 31 adalah -18.73 MM.
- Nilai net income untuk Vaccinex, Inc. per 2024 Dec 31 adalah -18.63 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | 0.60 | -18.73 | -18.63 |
2024-09-30 | 0.39 | -20.34 | -18.58 |
2024-06-30 | 0.36 | -21.62 | -17.76 |
2024-03-31 | 0.12 | -22.97 | -19.19 |
2023-12-31 | 0.57 | -22.89 | -20.25 |
2023-09-30 | 0.80 | -23.02 | -22.01 |
2023-06-30 | 0.82 | -21.97 | -21.86 |
2023-03-31 | 0.82 | -20.30 | -20.18 |
2022-12-31 | 0.28 | -19.91 | -19.82 |
2022-09-30 | 0.05 | -20.30 | -19.37 |
2022-06-30 | 0.05 | -20.58 | -19.82 |
2022-03-31 | 0.05 | -20.84 | -20.40 |
2021-12-31 | 0.90 | -22.49 | -22.38 |
2021-09-30 | 0.90 | -23.06 | -24.19 |
2021-06-30 | 1.48 | -26.58 | -27.74 |
2021-03-31 | 1.48 | -27.41 | -28.28 |
2020-12-31 | 0.62 | -28.33 | -28.85 |
2020-09-30 | 0.62 | -28.58 | -28.73 |
2020-06-30 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -8.88.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | -8.88 | |
2024-09-30 | -12.02 | -12.02 |
2024-06-30 | -15.88 | -15.88 |
2024-03-31 | -26.06 | -26.07 |
2023-12-31 | -43.68 | |
2023-09-30 | -82.69 | -82.69 |
2023-06-30 | -92.44 | -91.60 |
2023-03-31 | -93.73 | -93.47 |
2022-12-31 | -98.05 | |
2022-09-30 | -105.04 | -105.70 |
2022-06-30 | -116.38 | -118.27 |
2022-03-31 | -132.91 | -134.07 |
2021-12-31 | -162.91 | -163.80 |
2021-09-30 | -189.97 | -189.97 |
2021-06-30 | -242.13 | -242.13 |
2021-03-31 | -281.54 | -281.54 |
2020-12-31 | -322.50 | |
2020-09-30 | -357.31 | -357.31 |
2020-06-30 | -378.71 | -378.71 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Vaccinex, Inc. per 2024 Dec 31 adalah -16.19 MM.
- Nilai cash from investing activities untuk Vaccinex, Inc. per 2024 Dec 31 adalah -0.02 MM.
- Nilai kas dari aktivitas pendanaan untuk Vaccinex, Inc. per 2024 Dec 31 adalah 15.78 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | -16.19 | -0.02 | 15.78 |
2024-09-30 | -15.85 | -0.02 | 18.65 |
2024-06-30 | -15.73 | -0.03 | 14.09 |
2024-03-31 | -16.83 | -0.02 | 16.49 |
2023-12-31 | -21.38 | -0.07 | 16.59 |
2023-09-30 | -18.24 | -0.07 | 11.25 |
2023-06-30 | -19.29 | -0.10 | 9.90 |
2023-03-31 | -19.12 | -0.15 | 5.79 |
2022-12-31 | -19.07 | -0.10 | 16.98 |
2022-09-30 | -19.62 | -0.10 | 13.16 |
2022-06-30 | -21.53 | -0.06 | 10.61 |
2022-03-31 | -23.18 | -0.03 | 10.63 |
2021-12-31 | -25.30 | -0.03 | 23.32 |
2021-09-30 | -26.54 | -0.03 | 23.22 |
2021-06-30 | -29.79 | -0.06 | 51.70 |
2021-03-31 | -28.25 | -0.04 | 55.19 |
2020-12-31 | -28.65 | -0.29 | 36.76 |
2020-09-30 | -28.07 | -0.29 | 36.87 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -2.86.
- p/tbv untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -2.86.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | -2.86 | -2.86 | |
2024-09-30 | -0.33 | -2.06 | -2.06 |
2024-06-30 | -0.54 | 3.87 | 3.87 |
2024-03-31 | -0.40 | -2.26 | -2.26 |
2023-12-31 | -0.37 | -2.13 | -2.13 |
2023-09-30 | -0.25 | -12.74 | -12.74 |
2023-06-30 | -1.12 | 9.44 | 9.44 |
2023-03-31 | -1.03 | 3.16 | |
2022-12-31 | 5.09 | 5.09 | |
2022-09-30 | 1.97 | 1.97 | |
2022-06-30 | -2.26 | 2.85 | 2.85 |
2022-03-31 | 4.74 | ||
2021-12-31 | -1.32 | 2.69 | 2.69 |
2021-09-30 | -2.40 | 3.93 | 3.93 |
2021-06-30 | |||
2021-03-31 | -1.39 | 1.72 | 1.72 |
2020-12-31 | -1.07 | -11.83 | -11.83 |
2020-09-30 | -1.07 | 8.21 | 8.21 |
2020-06-30 | -0.85 | -4.21 | -4.21 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -7.63.
- EBIT (3 tahun) / EV untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -8.03.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | -7.63 | -8.03 |
2024-09-30 | -2.49 | -2.77 |
2024-06-30 | -2.22 | -2.31 |
2024-03-31 | -2.52 | -2.45 |
2023-12-31 | -2.67 | -2.65 |
2023-09-30 | -6.04 | -6.40 |
2023-06-30 | -1.04 | -1.16 |
2023-03-31 | -1.49 | -1.75 |
2022-12-31 | -0.77 | -0.96 |
2022-09-30 | -1.91 | -2.34 |
2022-06-30 | -0.69 | -0.86 |
2022-03-31 | 0.00 | -0.34 |
2021-12-31 | -1.10 | -1.29 |
2021-09-30 | -0.58 | -0.63 |
2021-06-30 | ||
2021-03-31 | -0.80 | -0.84 |
2020-12-31 | -0.54 | -0.56 |
2020-09-30 | -0.61 | -0.62 |
2020-06-30 | -0.57 | -0.58 |
Efektivitas Manajemen
- roa untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -5.12.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2024-12-31 | -5.12 | ||||
2024-09-30 | -6.94 | ||||
2024-06-30 | -3.92 | -7.99 | -6.76 | -0.12 | -5.92 |
2024-03-31 | -2.76 | -4.24 | |||
2023-12-31 | -2.56 | -3.48 | |||
2023-09-30 | -1.74 | -2.00 | |||
2023-06-30 | -1.61 | -1.84 | |||
2023-03-31 | -1.07 | -1.20 | -7.05 | -4.71 | -6.68 |
2022-12-31 | -1.28 | -1.63 | -2.82 | -0.96 | -2.86 |
2022-09-30 | -1.30 | -1.67 | -2.81 | -0.95 | -2.85 |
2022-06-30 | -0.86 | -1.20 | -1.76 | -0.98 | -1.92 |
2022-03-31 | 0.00 | 0.00 | -1.25 | ||
2021-12-31 | -2.07 | -2.00 | -0.18 | -1.71 | |
2021-09-30 | -1.29 | -7.37 | -1.56 | -0.22 | -1.45 |
2021-06-30 | -8.95 | -1.54 | 1.21 | -1.65 | |
2021-03-31 | -5.79 | -1.08 | 1.03 | -1.08 | |
2020-12-31 | -6.27 | 1.10 | -4.37 | 1.19 | -4.34 |
2020-09-30 | -2.66 | -7.34 | -2.25 | 0.67 | -2.19 |
2020-06-30 | -3.88 |
Gross Margins
- marjin kotor untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -41.72.
- marjin bersih untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -47.88.
- marjin operasi untuk Vaccinex, Inc. pada 2024 Dec 31 adalah -52.41.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2024-12-31 | -41.72 | -47.88 | -52.41 |
2024-09-30 | -41.02 | -49.88 | -60.72 |
2024-06-30 | -129.20 | -154.73 | -185.27 |
2024-03-31 | -16.58 | -27.69 | -28.95 |
2023-12-31 | -16.58 | -27.69 | -28.95 |
2023-09-30 | -18.43 | -26.50 | -26.64 |
2023-06-30 | -16.97 | -26.50 | -26.64 |
2023-03-31 | -282.84 | -24.46 | -24.60 |
2022-12-31 | -282.84 | -387.36 | -406.10 |
2022-09-30 | -286.84 | -387.36 | -406.10 |
2022-06-30 | -291.26 | -396.30 | -411.52 |
2022-03-31 | -408.02 | -416.88 | |
2021-12-31 | -22.94 | -24.87 | -24.99 |
2021-09-30 | -13.34 | -26.88 | -25.62 |
2021-06-30 | -13.34 | -18.81 | -18.02 |
2021-03-31 | -13.68 | -19.17 | -18.58 |
2020-12-31 | -33.48 | -46.16 | -45.33 |
2020-09-30 | -33.65 | -45.97 | -45.73 |
2020-06-30 | -50.66 | -68.36 | -68.50 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1205922 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |